USBC Inc (USBC)

[Regis999]

https://www.forbes.com/sites/danieldambrosio/2020/03/26/this-new-england-startup-has-an-analyzer-that-will-detect-coronavirus/#d3efdd87c853

Mar 26, 2020,09:43pm EDT

This New England Startup Is Developing An Analyzer That Will Detect Coronavirus


The person who headed up developing the Anthrax detection machine for the government in 2001 now has his own public diagnostic company utilizing the technology developed then.LexaGene is the public company (TSX.V: LXG OTCQB: Symbol LXXGF) with market cap of $ 59 million.

LexaGene is a biotechnology company developing genetic analyzers for pathogen detection and other molecular markers.

See LexaGene CoronaVirus Press Release

https://lexagene.com/release/2020/lx-analyzer-successfully-detects-coronavirus-rna/

Top Markets Targeted 1) Veterinary Diagnostics-(Market Size $5.4 Billion USD)-ONE Hour turnaround 2) Food Safety –e-Coli-Cannabis-Hemp-etc 48 million illnesses in US (Market Size $ 24 Billion) 3) Clinical Diagnostics ($12.9 Billion USD)-includes pandemics Other Water Safety/ Genotyping/Cruise Ships/Border Crossing etc.

Video testimonial from the veterinary team can be viewed in the following video. The following is a Video of the Beta Prototype TEST at Massachusetts Veterinary Referral Hospital (4 min):

https://lexagene.com/beta-testimonial-video/

References:

Lexagene Website

https://lexagene.com/

https://lexagene.com/subscribe/

Public Company Quote

https://finance.yahoo.com/quote/LXXGF?p=LXXGF

Lexagene Company Presentation

https://lexagene.com/wp-content/uploads/2020/02/LXG_Investor-Presentation_12Feb20web.pdf

This Machine Can Save a Million Lives in 60 Minutes (came out last week.
https://secure.outsiderclub.com/o/web/245869

Forbes “This New Device’s Rapid Pathogen Identification May Be Our Next Big Medical Breakthrough”

https://www.forbes.com/sites/jimvinoski/2019/12/10/this-new-devices-rapid-pathogen-identification-may-be-our-next-big-medical-breakthrough/#4fb24b082f63